• 대한비뇨기종양학회지
• /
• 제15권3호
• /
• pp.178-186
• /
• 2017

Purpose: Poloxamer 407 (P407) thermo-sensitive hydrogel formulations were developed to enhance the retention time in the urinary bladder after intravesical instillation. Materials and Methods: P407 hydrogels (P407Gels) containing 0.2 w/w% fluorescein isothiocyanate dextran (FD, MW 4 kDa) as a fluorescent probe were prepared by the cold method with different concentrations of the polymer (20, 25, and 30 w/w%). The gel-forming capacities were characterized in terms of gelation temperature (G-Temp), gelation time (G-Time), and gel duration (G-Dur). Homogenous dispersion of the probe throughout the hydrogel was observed by using fluorescence microscopy. The in vitro bladder simulation model was established to evaluate the retention and drug release properties. P407Gels in the solution state were administered to nude mice via urinary instillation, and the in vivo retention behavior of P407Gels was visualized by using an in vivo imaging system (IVIS). Results: P407Gels showed a thermo-reversible phase transition at $4^{\circ}C$ (refrigerated; sol) and $37^{\circ}C$ (body temperature; gel). The G-Temp, G-Time, and G-Dur of FD-free P407Gels were approximately $10^{\circ}C-20^{\circ}C$, 12-30 seconds, and 12-35 hours, respectively, and were not altered by the addition of FD. Fluorescence imaging showed that FD was spread homogenously in the gelled P407 solution. In a bladder simulation model, even after repeated periodic filling-emptying cycles, the hydrogel formulation displayed excellent retention with continuous release of the probe over 8 hours. The FD release from P407Gels and the erosion of the gel, both of which followed zero-order kinetics, had a linear relationship ($r^2=0.988$). IVIS demonstrated that the intravesical retention time of P407Gels was over 4 hours, which was longer than that of the FD solution (<1 hour), even though periodic urination occurred in the mice. Conclusions: FD release from P407Gels was erosion-controlled. P407Gels represent a promising system to enhance intravesical retention with extended drug delivery.

• Elastomers and Composites
• /
• 제19권1호
• /
• pp.13-31
• /
• 1984

The purposes of this dissertation are to demonstrate that DSC theromoanaytical methods of vulcanization can provide useful informations on the vulcanization characteristics of industrial formulations and also provides the potential basis for a rapid and complete method of sulfur and vulcanizing accelerator analysis for quality control. The influences of those factors such as heating rate, scan temperature, vucanizing accelerator's type and concentration upon vulcanization exotherm in NR and NBR compounds in the presence of vulcanizing accelerators such as TMTD,MBTS,DPG,TMTM,CBS, and MBT were evaluated by means of DSC. In order to examine the credibility in the DSC method, the same samples which were used for DSC method were studied to compare the DSC results with the ODR (Oscillating Disk Rheometer) data. The results obtained were as follows 1. In the DSC dynamic experiments, the observed enthalpy results from vulcanization depends upon the heating rate; In the range of 2 to $20^{\circ}C/min$ of heating rate, as the heating rate was increased the enthalpy change was also increased. However, over the heating rate of $30^{\circ}C/min$ it was observed that the enthalpy change was decreased as the heating rate was further increased. Without regard to the change of enthalpy, tremendous instantaneous heat evolving was observed in the range of high heating rates. 2. For the samples which are added with various vulcanizing accelerators, the activation energies of vulcanization were as follows; 3. Regarding to the influences of vulcanizining accelerator's types upon the characteristics of vulcanization exotherm, NR and NBR compounds in the presence of thiuramsulphide compounds type accelerators such as TMTD, TMTM, were exhibited sharper and higher vulclanization exotherm than others. From the resuts of DSC thermograms which was distributed in even shape in the broad temperature range, it was clearly shown that the guanidine compounds type accelerator such as DPG acts as a delayed acting accelerator. 4. In the comparison of DSC and ODR results, the dependency of temperature in the cure rate and the observed conversions show good agreements between two results. 5. In the same curatives, by the comparison of glass transition temperatures, it was possible to predict relative values of maximum torques. Consequently, from the present studies, it is shown that the DSC thermoanalytical method can provide an alternate new method for rapid and complete quality control analysis of rubber industry.

• Archives of Pharmacal Research
• /
• 제29권4호
• /
• pp.328-332
• /
• 2006

The bioequivalence and pharmacokinetics of alendronate sodium tablets were examined by determining the plasma concentration of alendronate. Two groups, consisting of 24 healthy volunteers, each received a 70 mg reference alendronate sodium tablet and a test tablet in a $2{\times}2$ crossover study. There was a 6-day washout period between doses. The plasma alendronate concentration was monitored for 7 h after the dose, using HPLC-Fluorescence Detector (FD). The area under the plasma concentration-time curve from time 0 to the last sampling time at 7 h $(AUC_{0-7h})$ was calculated using the linear-log trapezoidal rule. The maximum plasma drug concentration $(C_{max})$ and the time to reach $C_{max}(T_{max})$ were derived from the plasma concentration-time data. Analysis of variance was performed using logarithmically transformed $AUC_{0-7h}\;and\;C_{max}$, and untransformed $T_{max}$. For the test medication versus the reference medication, the $AUC_{0-7h}\;were\;87.63{\pm}29.27\;vs.\;102.44{\pm}69.96ng\;h\;mL^{-1}$ and the $C_{max}$ values were $34.29{\pm}13.77\;vs.\;38.47{\pm}24.39ng\;mL^{-1}$ respectively. The $90\%$ confidence intervals of the mean differences of the logarithmic transformed $AUC_{0-7h}$ and $C_{max}$ values were log 0.8234-log 1.1597 and log 0.8222-log 1.1409, respectively, satisfying the bioequivalence criteria guidelines of both the US Food and Drug Administration and the Korea Food and Drug Administration. The other pharmacokinetic parameters for the test drug versus reference drug, respectively, were: $t_{1/2},\;1.87{\pm}0.62\;vs.\;1.77{\pm}0.54\;h;\;V/F,\;2061.30{\pm}986.49\;vs.\;2576.45{\pm}1826.05\;L;\;CL/F,\;835.32{\pm}357.35\;vs.\;889.48{\pm}485.87\;L\;h^{-1}; K_{el},\;0.42{\pm}0.14\;vs.\;0.40{\pm}0.18\;h^{-1};\;Ka,\;4.46{\pm}3.63\;vs.\;3.80{\pm}3.64\;h^{-1};\;and\;T_{lag},\;0.19{\pm}0.09\;vs.\;0.18{\pm}0.06\;h$. These results indicated that two alendronate formulations(70-mg alendronate sodium) were biologically equivalent and can be prescribed interchangeably.

• 한국응용과학기술학회지
• /
• 제38권4호
• /
• pp.986-993
• /
• 2021

본 연구는 다시마 추출물을 첨가한 모질 개선 제형제를 제조하여 손상된 모발에 도포하여 손상 모발의 개선 효과를 알아보고자 하였다. 실험재료는 다시마 추출물 함량을 0 g, 2 g 4 g, 6 g 으로 다르게 하여 펌베이스제에 첨가하여 제형제를 제조하였다. 제조한 제형제로 8레벨로 탈색한 시료 모발에 도포 전과 후를 측정하여 비교 분석하였다. 측정방법은 모질 개선 효과를 알기 위해 인장강도, 메틸렌블루를 이용한 흡광도, 광택을 측정하였다. 연구결과의 신뢰성을 위해 통계분석을 하였다. 연구결과로 인장강도 측정결과는 8레벨에 4 g 과 6 g 을 함유한 제형제로 도포한 시료의 인장강도가 증가함을 알 수 있었다. 메틸렌블루를 이용한 흡광도 분석결과 모든 시료의 도포 전, 후의 변화는 도포 후의 값이 감소함을 알 수 있었다. 광택 측정결과는 모든 시료에서 큰 차이가 없음을 알 수 있었다. 결론은 다시마 추출물이 손상된 모발에 개선 효과가 있는 것을 알 수 있었다. 차후 다양한 추출물의 종류와 연구방법으로 손상모발에 개선효과가 있는지 연구가 필요하다.

• 생명과학회지
• /
• 제31권9호
• /
• pp.849-855
• /
• 2021

최근에는 나노기술이 다양한 분야에 도입되고 활용되면서 신약개발이 가속화되고 있다. 나노입자는 약물의 단일 투여로 장기간 동안 혈중 약물 농도를 유지하고, 병리학적 부위에만 선택적으로 방출되는 장점이 있어 비병리 주위에 대한 부작용을 줄일 수 있다. Poly (D,L-lactic-co-glycolic acid) (PLGA)는 가장 광범위하게 개발된 생분해성 고분자 중 하나이다. PLGA는 다양한 응용분야의 약물전달에 널리 사용된다. 또한 FAD에 의해 약물전달 시스템으로 승인되었으며, 유전자 치료제와 같은 제어방출제형에 널리 적용된다. PLGA 나노입자는 수동 및 능동 표적화 방법을 사용하여 특정 세포 유형에 고효율의 전달 시스템으로 개발되었다. 이러한 PLGA 나노입자를 이용한 약물전달체 개발 후 표적 부위에 선택적으로 약물을 전달하고 질병에 따라 장기간 유효 혈중 농도를 최적화한다. 이 리뷰논문에서 우리는 유전자 치료를 위한 PLGA 나노 물질을 기반으로 하는 성상 세포 선택적 나노입자의 개발을 조사하여 세포 특이적으로 치료결과를 향상시키는 방법에 중점을 두고자 한다.

• 대한화장품학회지
• /
• 제47권3호
• /
• pp.227-235
• /
• 2021

자외선 및 블루영역 차단 기능을 갖는 화장품의 원료로 사용되기 위한 박막 판형의 ZnO 및 Fe₂O₃ 성분을 포함하는 인공 칼라민 세라믹 분말 소재를 합성하였다. 20 : 1에서 50 : 1 범위의 높은 종횡비를 가지는 (0001)면의 판형 ZnO 세라믹 분말 소재는 아연공기전지로 전력 생산한 후에 회수한 전해질을 출발 물질로 하여 징크아세테이트와 소듐시트레이트 혼합 용액에서 중화반응을 통한 석출로 합성하였다. 아이언 클로라이드 용액의 첨가량을 증가시키는 방법으로 인공 칼라민 세라믹 분말 내의 Fe₂O₃ 함량을 높일 수 있었으며, 이 경우 자외선뿐만 아니라 가시광선의 블루 영역을 일부 흡수하였다. 포타슘 아세테이트 용액을 첨가시킬 경우에는 Zn(OH)₄^2- 음이온의 분해를 촉진하여 (0001) 면 위에 수직 방향으로 격벽 형태로 성장한 박막을 얻을 수 있었는데, 이 경우 자외선을 흡수할 수 있는 기회가 증가하면서 자외선 흡수율이 증가하였다. 아이언 클로라이드 용액과 포타슘 아세테이트 용액의 첨가량을 함께 조절하면 박막 판형의 인공 칼라민 세라믹 분말의 조성 및 형상을 최적화시킬 수 있어서 화장품 제형을 진행할 경우 블루영역의 광투과도가 크게 감소하였다.

• 대한화장품학회지
• /
• 제47권3호
• /
• pp.265-271
• /
• 2021

나노입자(nanoparticles)는 그 크기가 피부를 구성하는 세포보다 작다. 따라서 세포막을 통과하고 약물 또는 유전자를 전달하는 매개체로서의 역할에 매우 적합하며 특정 성분을 피부 속에 전달할 수도 있다. 본 연구에서는 쑥으로부터 나노입자를 추출하여 dynamic light scattering (DLS)를 통해 100 nm 전후 크기의 입자를 얻었음을 확인하였고, MTT assay를 통하여 섬유아세포에서 cell viability를 농도 의존적으로 증진시키는 결과를 얻었다. 또한, quantitative real time PCR 분석법을 통해서 COL1A1 mRNA 발현량을 증가시키고 IL-6 mRNA 발현량은 감소시킴을 확인하였다. 세포실험뿐 아니라 화장품 제형에서도 적용 가능하며, 안정함을 확인하였다. 최근 화장품 산업 동향에서 화학 성분을 배제하고 식물 유래 성분 수요가 지속적으로 높아지고 있는 반면, 식물에서 유래된 나노입자의 응용분야를 제시하는 연구 결과가 거의 없다는 한계가 있다. 따라서 현시점에서의 화장품 산업의 한계점을 극복하고자 본 연구를 통해 얻은 결과를 견주어 쑥으로부터 유래된 나노입자를 고기능성 화장품 소재로서 제시하고자 한다.

• 동의생리병리학회지
• /
• 제32권6호
• /
• pp.384-395
• /
• 2018

The aim of this study was to investigate whether a novel formulation of an herbal extracts has an inhibitory effect on obesity. To determine its anti-obesity effects, we performed anti-obesity-related experiments in vitro and in vivo. Thus, our present study was carried out to evaluate the anti-obesity effect of herbal extracts using a high fat diet (HFD)-induced obese mouse model and 3T3-L1 adipose cells. The effects of each herbal extracts on lipid accumulation in 3T3-L1 cells were examined using Oil Red O staining. Results showed that treatment with each herbal extracts at $10{\sim}100{\mu}g/ml$ had no effect on cell morphology and viability. Without evidence of toxicity, herbal extracts treatment decreased lipid accumulation compared with the untreated adipocytes controls as shown by the lower absorbance of Oil Red O stain. Futhermore, compared with control-differentiated mature adipocytes, each herbal extracts significantly inhibited lipid accumulation in mature 3T3-L1 adipocytes. In the HFD-fed obese mice, body weight, liver weight and white adipose tissue weights were significantly reduced by mixture of herbal extracts administration in mouse skin. Futhermore, we found that mixture of herbal extracts administration suppressed serum triglyceride (TG), and total cholesterol (TCHO) in HFD-induced obese mouse model. The mixture of herbal extracts of permeability was estimated by measuring the transepithelial electrical resistance (TEER) value in pig skin. The optimized formulations of herbal extracts (Test 3 formulation) showed skin permeation. However, test 1 formulation containing essential oil as enhancer showed maximum skin permeation. After confirming the enhanced skin permeability, in vivo studies were performed to assess whether skin irritation potential on the basis of a primary irritation index (PII) in rabbit skin. Reactions were scored for erythema/edema reactions at 24 h, 48 h and 72 h post-application. It was concluded that the test 1 formulation was not irritation (PII = 0). The present study suggests that the test 1 formulation might be of therapeutic interest with respect to the treatment of obesity.

• 한국응용과학기술학회지
• /
• 제36권2호
• /
• pp.592-599
• /
• 2019

This study is to stabilize insoluble and unstable active ingredient which is Idebenone (INCI name: hydroxydecyl ubiquinone) in a multi-lamellar vesicle (MLV) and to stabilize it in the skin care cosmetics. Idebenone is good effective raw material in the treatment of Alzheimer's disease in the medical field and a powerful antioxidant in dermatology. It is well known as a substance that inhibits the formation of melanin and cleans the skin pigment. However, it did not dissolve in any solvent and it was difficult to apply in cosmetic applications. Niosome vesicle was able to develop a nano-particle by making a multi-layer of idebenone encapsulated with a nonionic surfactant, hydrogenated lecithin and glycine soja (soybean) sterols and passing it through a high pressure microfluidizer. Idebenone niosome vesicle (INV) has been developed to have the ability to dissolve transparently in water and to promote transdermal penetration. The appearance of the INV was a yellowish liquid having specific odor, and the particle size distribution of INV was about 10~80 nm. The pH was 5~8 (mean=6.8). This capsulation with idebenone was stored in a $45^{\circ}C$ incubator for 3 months and its stability was observed and quantitatively measured by HPLC. As a result, the stability of the sample encapsulated in the niosome vesicle (97.5%) was about 66.3% higher than that of the non-capsule sample of 32.5%. Idebenone 1% INV was used for the efficacy test and clinical trial evaluation as follows. The anti-oxidative activity of INV was 38.2%, which was superior to that of 12.8% tocopherol (control). The melanin-reducing effect of B16 melanoma cells was better than INV (17.4%) and Albutin (control) (9.6%). Pro-collagen synthesis rate was 128.2% for INV and 89.3% for tocopherol (control). The skin moisturizing effect was 15.5% better than the placebo sample. The elasticity effect was 9.7% better than the placebo sample. As an application field, INV containing 1% of idebenone is expected to be able to develop various functional cosmetic formulations such as skin toner, ampoule essence, cream, eye cream and sunblock cream. In addition, it is expected that this encapsulated material will be widely applicable to emulsifying agents for skin use in the pharmaceutical industry as well as the cosmetics industry.

• 한국응용과학기술학회지
• /
• 제36권2호
• /
• pp.434-447
• /
• 2019

폴리에틸렌글라이콜(PEG)은 계면활성제, 세정제, 유화제 등으로 화장품에 많이 사용된다. 이들은 제조 과정 중, ethylene oxide의 이량체화에 의해 인간에 몸에 유해한 1,4-dioxane이 부산물로 생성될 수 있다. 화장품 성분에 대한 소비자들의 관심이 증가함에 따라, 퍼스널케어 시장에서 PEG 성분이 없는 보다 안전한 에멀젼 연구의 필요성이 증대되고 있다. PEG-free 계면활성제로 사용되는 polyglycerol ester (PGE)는 비이온성 계면활성제로서 식품, 화장품 등의 분야에서 많이 사용되며 글리세롤과 지방산을 에스테르화 하여 생산된다. 본 연구에서는 PEG 성분을 함유하지 않은 나노에멀젼 제형의 개발 및 안정화를 목표로 하였다. 최적화된 나노에멀젼 제형 개발을 위해 RSM (Response Surface Methodology)를 사용하였다. 독립변수 및 변수의 범위 결정을 위한 예비 실험의 결과로 계면활성제 함량(2~4%), 오일 함량(4~8%), 폴리올 함량(12~24%)을 독립변수로 설정하였다. 반응변수로는 제형의 입자 크기(particle size), 제타 전위(zeta potential), 현탁도(turbidity), 다분산지수(polydispersity index)를 측정하였다. 제조한 나노에멀젼을 FIB (Focused ion beam)로 측정한 결과, 구형의 입자들이 100~200 nm의 크기를 가지고 분포되어 있는 것을 확인하였다. 제조된 제형에 대해 30일 간 각 온도별($4^{\circ}C$, $25^{\circ}C$, $45^{\circ}C$) 안정성 평가를 진행하였고, 최적의 입자 크기, 현탁도, 다분산지수, 제타 전위를 고려한 최적의 처방은 계면활성제(2%), 오일(8%), 폴리올(24%)로 확인되었다.